Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in ArgentinaLOPEZ, H; STEPANIK, D; VILCHES, V et al.Diagnostic microbiology and infectious disease. 2001, Vol 40, Num 4, pp 187-192, issn 0732-8893Article

Assessment of pharmacokinetic-pharmacodynamic target attainment of gemifloxacin against Streptococcus pneumoniaeOWENS, Robert C; BHAVNANI, Sujata M; AMBROSE, Paul G et al.Diagnostic microbiology and infectious disease. 2005, Vol 51, Num 1, pp 45-49, issn 0732-8893, 5 p.Article

Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panelsROSS, James E; SADER, Helio S; FRITSCHE, Thomas R et al.Diagnostic microbiology and infectious disease. 2005, Vol 51, Num 3, pp 219-221, issn 0732-8893, 3 p.Article

Cutaneous adverse events and gemifloxacin : Observations from the clinical trial programIANNINI, P; MANDELL, L; PATOU, G et al.Journal of chemotherapy. 2006, Vol 18, Num 1, pp 3-11, issn 1120-009X, 9 p.Article

Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypesPOTTUMARTHY, Sudha; FRITSCHE, Thomas R; JONES, Ronald N et al.Diagnostic microbiology and infectious disease. 2006, Vol 54, Num 2, pp 127-134, issn 0732-8893, 8 p.Article

In vitro susceptibility of 4903 bacterial isolates to gemifloxacin: an advanced fluoroquinoloneBLONDEAU, J. M; HANSEN, G; METZLER, K. L et al.International journal of antimicrobial agents. 2003, Vol 22, Num 2, pp 147-154, issn 0924-8579, 8 p.Article

Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: Advantage of IE over other integral parametersFIRSOV, A. A; ZINNER, S. H; LUBENKO, I. Y et al.Chemotherapy (Basel). 2002, Vol 48, Num 6, pp 275-279, issn 0009-3157, 5 p.Article

Effect of calcium carbonate on bioavailability of orally administered gemifloxacinPLETZ, M. W; PETZOLD, P; ALLEN, A et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 7, pp 2158-2160, issn 0066-4804, 3 p.Article

Gemifloxacin for the management of community-acquired respiratory tract infectionsBLONDEAU, J. M; TILLOTSON, G; DEANGELIS, J et al.Journal of chemotherapy. 2006, Vol 18, Num 6, pp 582-588, issn 1120-009X, 7 p.Article

Antimicrobial activity and a comparison of published pharmacodynamics of gemifloxacin and eight fluoroquinolones against Streptococcus pneumoniaeSARAVOLATZ, Louis; MANZOR, Odette; PAWLAK, Joan et al.International journal of antimicrobial agents. 2005, Vol 26, Num 1, pp 81-84, issn 0924-8579, 4 p.Article

Gemifloxacin: effects of sub-inhibitory concentrations on various factors affecting bacterial virulenceDAL SASSO, M; CULICI, M; BOVIO, C et al.International journal of antimicrobial agents. 2003, Vol 21, Num 4, pp 325-333, issn 0924-8579, 9 p.Article

Application of two methods to determine killing of Streptococcus pneumoniae by various fluoroquinolonesBLONDEAU, J. M; BLONDEAU, L. D; HESJE, C et al.Journal of chemotherapy. 2006, Vol 18, Num 4, pp 366-372, issn 1120-009X, 7 p.Article

Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic studyKAISER, Moacir; GRÜNSPAN, Lauren D; COSTA, Teresa Dalla et al.Journal of chromatography. B. 2011, Vol 879, Num 30, pp 3639-3644, issn 1570-0232, 6 p.Article

Gemifloxacin : A new treatment option in acute bacterial sinusitis = Gémifloxacine : un nouveau traitement de la sinusite bactérienne aiguëANON, J; TILLOTSON, G.Antibiotiques (Paris). 2008, Vol 10, Num 4, pp 199-208, issn 1294-5501, 10 p.Article

Clinical characteristics and response to newer quinolones in Legionella pneumonia: A report of 28 casesSANTOS, J; AGUILAR, L; GARCIA-MENDEZ, E et al.Journal of chemotherapy. 2003, Vol 15, Num 5, pp 461-465, issn 1120-009X, 5 p.Article

Gemifloxacin-associated neurotoxicity presenting as encephalopathyBARRETT, Matthew J; LOGIN, Ivan S.The Annals of pharmacotherapy. 2009, Vol 43, Num 4, pp 782-784, issn 1060-0280, 3 p.Article

Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against PneumococciCREDITO, Kim; KOSOWSKA-SHICK, Klaudia; MCGHEE, Pamela et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 2, pp 673-677, issn 0066-4804, 5 p.Article

Synthesis of carbon-14 labelled gemifloxacinHYUN IL SHIN; JONG GILL RIM; KI SEUNG LEE et al.Journal of labelled compounds & radiopharmaceuticals. 2004, Vol 47, Num 11, pp 779-786, issn 0362-4803, 8 p.Article

Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic modelPORTNOY, Yury A; VOSTROV, Sergey N; LUBENKO, Irene Yu et al.International journal of antimicrobial agents. 2002, Vol 20, Num 3, pp 201-205, issn 0924-8579, 5 p.Article

Competitive Inhibition of Renal Tubular Secretion of Gemifloxacin by ProbenecidLANDERSDORFER, Cornelia B; KIRKPATRICK, Carl M. J; KINZIG, Martina et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 9, pp 3902-3907, issn 0066-4804, 6 p.Article

Concentrations of gemifloxacin at the target site in healthy volunteers after a single oral doseISLINGER, Florian; BOUW, Rene; STAHL, Mathias et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 11, pp 4246-4249, issn 0066-4804, 4 p.Article

Ultrastructural changes of the gemifloxacin on achilles tendon in immature rats : Comparison with those of ciproxacin and ofloxacinBAE, Chun-Sik; OH, Dong-Min; BAE, Jin-Gyu et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 98, Num 4, pp 406-410, issn 1742-7835, 5 p.Article

Mechanism of fluoroquinolone resistance is an important factor in determining the antimicrobial effect of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelMACGOWAN, Alasdair P; BOWKER, Karen E.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 3, pp 1096-1100, issn 0066-4804, 5 p.Article

In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IVGARRISON, Mark W; SCHIMMELS, Julie A; MADARAS-KELLY, Karl J et al.Diagnostic microbiology and infectious disease. 2003, Vol 47, Num 4, pp 587-593, issn 0732-8893, 7 p.Article

Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolonesRUIZ, Joaquim; JURADO, Angels; GARCIA-MENDEZ, Elena et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 48, Num 4, pp 545-548, issn 0305-7453Article